Literature DB >> 18506638

Effect of treatment of elevated blood pressure on neurological deterioration in patients with acute intracerebral hemorrhage.

M Fareed K Suri1, Jose I Suarez, Tina C Rodrigue, Osama O Zaidat, Gabriela Vazquez, Andrew Wensel, Warren R Selman.   

Abstract

INTRODUCTION: Treatment of elevated blood pressure after acute intracerebral hemorrhage (ICH) is controversial. There is a risk of hematoma expansion with elevated blood pressure, and risk of ischemia with blood pressure control. This study was done to determine the effect of blood pressure control on outcome.
METHODS: We retrospectively studied 122 patients with ICH. We collected 24-h blood pressure readings on all patients. The Glasgow Coma Score (GCS) at baseline and at 24 h was used to determine neurological deterioration (GCS decline > or = 2). Baseline computerized tomography (CT) scans were reviewed for hematoma volume, intraventricular hemorrhage, and location of hemorrhage. Drops in systolic blood pressure and mean arterial pressures over 24 h were divided in quartiles to determine the risk of neurological deterioration among quartiles. A logistic regression model was used to determine the association between variables of interest and neurological deterioration.
RESULTS: Neurological deterioration was observed in 12 patients (10%). Baseline blood pressure and GCS were only two variables significantly different among quartiles of blood pressure drop. Multivariable adjusted analysis for these variables demonstrated significant trend toward reduced neurological deterioration with maximum blood pressure drop (systolic or mean). The risk of neurological deterioration was significantly lower in the quartile of maximum drop of systolic (odds ratio [OR] 0.02, 95% confidence interval [CI] 0.0-0.68) or mean (OR 0.03, 95% CI 0.0-0.98) blood pressure when compared to the quartile with least drop.
CONCLUSION: This study supports that reduction of blood pressure in patients with acute ICH is safe and suggests that aggressive reduction might reduce the risk of neurological deterioration in first 24 h of admission.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18506638     DOI: 10.1007/s12028-008-9106-7

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  17 in total

1.  Progression of hypertensive intracerebral hemorrhage.

Authors:  S T Chen; S D Chen; C Y Hsu; E L Hogan
Journal:  Neurology       Date:  1989-11       Impact factor: 9.910

2.  Medical treatment of spontaneous intracranial hemorrhage by the use of hypotensive drugs.

Authors:  J S MEYER; R B BAUER
Journal:  Neurology       Date:  1962-01       Impact factor: 9.910

Review 3.  Acute hypertension after stroke: the scientific basis for treatment decisions.

Authors:  W J Powers
Journal:  Neurology       Date:  1993-03       Impact factor: 9.910

4.  A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage.

Authors:  Adnan I Qureshi; Yousef M Mohammad; Abutaher M Yahia; Jose I Suarez; Amir M Siddiqui; Jawad F Kirmani; M Fareed K Suri; James Kolb; Osama O Zaidat
Journal:  J Intensive Care Med       Date:  2005 Jan-Feb       Impact factor: 3.510

5.  Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model.

Authors:  A I Qureshi; D L Bliwise; N G Bliwise; M S Akbar; G Uzen; M R Frankel
Journal:  Crit Care Med       Date:  1999-03       Impact factor: 7.598

6.  Early hemorrhage growth in patients with intracerebral hemorrhage.

Authors:  T Brott; J Broderick; R Kothari; W Barsan; T Tomsick; L Sauerbeck; J Spilker; J Duldner; J Khoury
Journal:  Stroke       Date:  1997-01       Impact factor: 7.914

7.  Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group.

Authors:  Joseph Broderick; Sander Connolly; Edward Feldmann; Daniel Hanley; Carlos Kase; Derk Krieger; Marc Mayberg; Lewis Morgenstern; Christopher S Ogilvy; Paul Vespa; Mario Zuccarello
Journal:  Stroke       Date:  2007-05-03       Impact factor: 7.914

8.  Ultra-early evaluation of intracerebral hemorrhage.

Authors:  J P Broderick; T G Brott; T Tomsick; W Barsan; J Spilker
Journal:  J Neurosurg       Date:  1990-02       Impact factor: 5.115

9.  Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course.

Authors:  S Kazui; H Naritomi; H Yamamoto; T Sawada; T Yamaguchi
Journal:  Stroke       Date:  1996-10       Impact factor: 7.914

10.  Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors.

Authors:  R Leira; A Dávalos; Y Silva; A Gil-Peralta; J Tejada; M Garcia; J Castillo
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

View more
  6 in total

1.  Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage.

Authors:  Magdy Selim; Sharon Yeatts; Joshua N Goldstein; Joao Gomes; Steven Greenberg; Lewis B Morgenstern; Gottfried Schlaug; Michel Torbey; Bonnie Waldman; Guohua Xi; Yuko Palesch
Journal:  Stroke       Date:  2011-08-25       Impact factor: 7.914

2.  High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods.

Authors:  Sharon D Yeatts; Yuko Y Palesch; Claudia S Moy; Magdy Selim
Journal:  Neurocrit Care       Date:  2013-10       Impact factor: 3.210

Review 3.  Evolution of blood pressure management in acute intracerebral hemorrhage.

Authors:  Stacy Chu; Lauren Sansing
Journal:  F1000Res       Date:  2017-11-21

Review 4.  Hypertensive Crisis in Acute Cerebrovascular Diseases Presenting at the Emergency Department: A Narrative Review.

Authors:  Mariagiovanna Cantone; Giuseppe Lanza; Valentina Puglisi; Luisa Vinciguerra; Jaime Mandelli; Francesco Fisicaro; Manuela Pennisi; Rita Bella; Rosella Ciurleo; Alessia Bramanti
Journal:  Brain Sci       Date:  2021-01-07

Review 5.  Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage.

Authors:  Amy Corbin Farr; May P Xiong
Journal:  Mol Pharm       Date:  2020-10-09       Impact factor: 4.939

Review 6.  Blood Pressure in Acute Ischemic Stroke.

Authors:  Michael McManus; David S Liebeskind
Journal:  J Clin Neurol       Date:  2016-01-28       Impact factor: 3.077

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.